{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:32Z","timestamp":1761630392679},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T00:00:00Z","timestamp":1132272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T00:00:00Z","timestamp":1132272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1111\/j.1365-2133.2005.07010.x","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T23:36:49Z","timestamp":1132357009000},"page":"191-192","source":"Crossref","is-referenced-by-count":50,"title":["Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab"],"prefix":"10.1093","volume":"154","author":[{"given":"K-Y.","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.L.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Medenica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,11,18]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3816\/CLC.2003.n.016","article-title":"Dermatologic side effects associated with gefitinib therapy: clinical experience and management","volume":"4","author":"Herbst","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","article-title":"Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225","volume":"144","author":"Busam","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2005.02.011","article-title":"The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies","volume":"53","author":"Kondapalli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.2005.04.057","article-title":"Practical management of patients with non-small-cell lung cancer treated with gefitinib","volume":"23","author":"Shah","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1200\/JCO.2004.02.168","article-title":"Complications of therapy in cancer patients. Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer","volume":"22","author":"Chang","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB6|cit6","first-page":"23","article-title":"Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD 1839), an inhibitor of epidermal growth factor","volume":"83","author":"Lee","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1046\/j.1365-2133.1999.02883.x","article-title":"Paronychia associated with antiretroviral therapy","volume":"140","author":"Tosti","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(84)80289-3","article-title":"Paronychia and pyogenic granuloma-like lesions with isotretinoin","volume":"4","author":"Blumental","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09546639009086719","article-title":"Retinoids and the nails","volume":"1","author":"Baran","year":"1990","journal-title":"J Dermatol Treat"},{"key":"10.1111\/j.1365-2133.2005.07010.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv Dent Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.07010.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.07010.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:15:25Z","timestamp":1676384125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/154\/1\/191\/6636846"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2005,11,18]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.07010.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11,18]]}}}